Get Your Personalized Supplement StackSupplement Stack Quiz

Salvia Root

Q: Is Salvia Root safe for long-term use?

Current evidence supports short- to medium-term safety, typically up to a few months. However, long-term safety data are limited, and more research is needed to confirm its safety for extended periods.

Q: Can it be used alongside conventional medications?

Generally, yes, but caution is advised, especially with anticoagulant or antiplatelet medications due to its mild blood-thinning effects. Always consult a healthcare professional before combining supplements with prescription drugs.

Q: How soon can benefits be expected?

Clinical improvements are typically observed within weeks to a few months, depending on the specific condition being treated and individual response. Consistency in usage is important for optimal results.

Q: Does it cure chronic diseases?

Salvia Root is considered a complementary therapy. It may help improve symptoms and delay the progression of chronic conditions, but it is not a cure. It should be used as part of a comprehensive treatment plan.

Also known as: Salvia Root, Danshen, Chinese sage root, Salvianolate, Tanshinone, Salvia miltiorrhiza

Overview

Salvia miltiorrhiza, commonly known as Salvia Root or Danshen, is a perennial plant native to China and East Asia, traditionally used in Traditional Chinese Medicine (TCM) for various health conditions, particularly those related to cardiovascular health. It is classified as an herbal supplement and phytotherapeutic agent. The dried root of the plant is the primary source of its medicinal properties. Key bioactive compounds include lipophilic diterpenoids (Tanshinones) and hydrophilic phenolic acids (Salvianolate), which contribute to its antioxidant, anti-inflammatory, and vasodilatory effects. Research on Salvia Root is moderate, with multiple randomized controlled trials (RCTs) and meta-analyses, predominantly from China. It is increasingly studied as a complementary therapy for chronic kidney disease (CKD), polycystic ovary syndrome (PCOS), lower urinary tract symptoms (LUTS), and endometriosis, showing promising results in these areas. While evidence is promising, further high-quality RCTs are needed to solidify its efficacy and safety profile.

Benefits

Salvia Root offers several evidence-based benefits, primarily as an adjunctive therapy. For Chronic Kidney Disease (CKD), meta-analyses suggest that *S. miltiorrhiza* extracts can improve kidney function markers and delay disease progression, though the certainty of evidence is currently suboptimal. In Polycystic Ovary Syndrome (PCOS), combining *S. miltiorrhiza* extract with letrozole significantly improved pregnancy rates (RR 2.60; 95% CI: 1.06–6.39; p=0.04) compared to letrozole alone, indicating a clinically meaningful effect. For endometriosis, meta-analyses show that *S. miltiorrhiza*-containing Chinese herbal medicine, when combined with GnRH-a, significantly reduced recurrence rates (RR = 0.26; 95% CI: 0.16–0.41). Preliminary data also suggest improvements in Lower Urinary Tract Symptoms (LUTS). While potential improvements in metabolic parameters and reproductive hormone profiles have been reported, more robust confirmation is needed. Benefits are primarily observed in patients with CKD, PCOS, endometriosis, and men with LUTS. Most studies range from weeks to a few months, and long-term effects are still being established.

How it works

Salvia Root exerts its therapeutic effects primarily through antioxidant and anti-inflammatory mechanisms, which help reduce oxidative stress and fibrosis in various tissues. It also promotes vasodilation, improving microcirculation, particularly in renal, reproductive, and cardiovascular systems. Its active compounds, Tanshinones and Salvianolate, modulate key biological pathways such as NF-κB signaling and TGF-β pathways, which are involved in inflammation and tissue remodeling. In reproductive tissues, it may also influence androgen receptor modulation. The bioavailability of lipophilic Tanshinones can be limited due to poor water solubility, and formulations often aim to enhance their absorption to maximize therapeutic efficacy.

Side effects

Salvia Root is generally well tolerated, with no significant adverse effects consistently reported in meta-analyses. Mild gastrointestinal discomfort has been noted in some cases, but this is uncommon (1-5%). Rare instances of allergic reactions (<1%) have been reported. A key safety consideration is its potential interaction with anticoagulant and antiplatelet drugs due to its mild blood-thinning effects; caution is advised for individuals on these medications or those with bleeding disorders. Therefore, it is contraindicated in patients with bleeding disorders or those undergoing surgery. Pregnant and breastfeeding women should avoid its use due to insufficient safety data in these specific populations. Overall, its safety profile appears favorable for short- to medium-term use, but long-term safety data are limited.

Dosage

The recommended dosage of Salvia Root varies depending on the specific extract and the condition being addressed. Clinical studies typically use standardized root extracts, with doses ranging from 400 mg to 800 mg per day. This range appears to be the optimal dosage for achieving therapeutic effects while maintaining safety. The maximum safe dose is not definitively established, but doses up to 800 mg/day have been well-tolerated in clinical trials. Salvia Root is usually administered orally, either once or twice daily. For consistent efficacy, standardized extracts containing specific amounts of Salvianolate or Tanshinone compounds are preferred. Due to the limited bioavailability of some lipophilic compounds, formulations designed to enhance absorption may be beneficial. No specific cofactors are identified as necessary for its efficacy, but general nutritional support is always advisable.

FAQs

Is Salvia Root safe for long-term use?

Current evidence supports short- to medium-term safety, typically up to a few months. However, long-term safety data are limited, and more research is needed to confirm its safety for extended periods.

Can it be used alongside conventional medications?

Generally, yes, but caution is advised, especially with anticoagulant or antiplatelet medications due to its mild blood-thinning effects. Always consult a healthcare professional before combining supplements with prescription drugs.

How soon can benefits be expected?

Clinical improvements are typically observed within weeks to a few months, depending on the specific condition being treated and individual response. Consistency in usage is important for optimal results.

Does it cure chronic diseases?

Salvia Root is considered a complementary therapy. It may help improve symptoms and delay the progression of chronic conditions, but it is not a cure. It should be used as part of a comprehensive treatment plan.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9213127/ – This meta-analysis of randomized controlled trials (RCTs) investigated *S. miltiorrhiza* as an adjunct therapy for Chronic Kidney Disease (CKD). It found that the extract improved kidney function markers and delayed disease progression without significant adverse events. However, the study noted limitations including a moderate risk of bias and low certainty of evidence, suggesting a need for higher quality research.
https://onlinelibrary.wiley.com/doi/10.1155/2021/9971403 – This systematic review and meta-analysis, including six RCTs with 390 patients, evaluated the effect of *S. miltiorrhiza* combined with letrozole for Polycystic Ovary Syndrome (PCOS). It concluded that the combination significantly increased pregnancy rates compared to letrozole alone (RR 2.60, p=0.04). The study highlighted the moderate quality of included studies and the need for larger-scale trials.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.831850/full – This meta-analysis of RCTs examined the efficacy of *S. miltiorrhiza*-containing herbal medicine combined with GnRH-a for endometriosis. The findings indicated a significant reduction in endometriosis recurrence rates (RR=0.26). While acknowledging concerns about the risk of bias due to lack of blinding in some studies, the objective outcome measures strengthened the findings, supporting its potential as an adjunctive therapy.